-Business Standard Both sides make claims and counter claims over who owes money to whom in plea filed before Bombay HC by Monsanto Hyderabad: The rising dispute between Monsanto and the Indian seed companies over the quantum of trait value being fixed towards the transfer of BT Cotton technology reached to a peak with both the parties making claims and counter claims over who vows the money to whom in a petition...

-Outlook Scientist and longtime activist against genetically modified BT seeds, Dr. Vandana Shiva, talks about why BT has a devastating fallout. A sudden pest attack has ruined cotton crops in large parts of Punjab, bringing biotech, or BT Cotton back into focus. Farmers who used bio-fertilisers in the Malwa region of the state are said to be safe from this latest pestilence. But those growing BT cotton have lost everything. There...

-Economic and Political Weekly India needs to find an optimal patenting regime that will safeguard incentives for innovation while simultaneously ensuring that medicines are available at reasonable prices. Viswanath Pingali (viswanath@iimahd.ernet.in) is at the Indian Institute of Management, Ahmedabad. Chirantan Chatterjee (chirantan@gmail.com) is at the Indian Institute of Management Bangalore. We gratefully acknowledge several discussions with Kensuke Kubo. Please click here to access the article. ...

-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...

-The Times of India NEW DELHI: Cancer medicines and stents may soon be available at a substantially lower price. The health ministry is working on a model to procure such drugs in bulk at a negotiated price and supply them to hospitals and consumers through its own retail system like 'Jan Aushadhi' stores. . The idea is to bring down prices of expensive cancer drugs and stents while not putting pressure on...